F Finsnes, OH Skjonsberg, T Tonnessen, O Naess, T Lyberg and G Christensen
Department of Pulmonary Medicine, University of Oslo, Ulleval Hospital, Norway.

Endothelin (ET) has strong bronchoconstrictor properties, stimulate mucus secretion and mucosal edema, and may also exert proinflammatory effects. Therefore, ET may play a pathogenic role in inflammatory airway diseases such as bronchial asthma. The production and localization of ET and the effect of blocking ET receptors was investigated in rats during airway inflammation induced by intratracheal instillation of dextran (Sephadex). We observed a considerable increase in the concentration of ET in bronchoalveolar lavage fluid (BALF) during the early phase of inflammation, with an increase from 2.2 +/- 0.6 pg/ml in controls to 40.0 +/- 6.7 pg/ml at Day 1, declining to 5.3 +/- 1.1 pg/ml at Day 14. Correlated with the ET response in BALF was a considerable increase in total cell count (r = 0.61), eosinophils (r = 0.83), and neutrophils (r = 0.81). Plasma ET was not elevated. Immunohistochemical analyses revealed ET-like staining in the bronchial epithelium. Treatment with the ET receptor antagonist bosentan inhibited the increase in eosinophils in BALF and reduced the inflammatory reaction in the lung tissue. In summary, a considerable increase in the ET concentration in BALF was demonstrated during the acute phase of an experimental eosinophilic airway inflammation, coinciding with an increased ET-like immunostaining in the bronchial epithelium. Treatment with an ET receptor antagonist inhibited the inflammatory response in BALF and in the tissue.

This article has been cited by other articles:

				L. De Franceschi, O. S. Platt, G. Malpeli, A. Janin, A. Scarpa, C. Leboeuf, Y. Beuzard, E. Payen, and C. Brugnara Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice FASEB J, June 1, 2008; 22(6): 1849 - 1860. [Abstract] [Full Text] [PDF]

				M. Metz, V. Lammel, B. F. Gibbs, and M. Maurer Inflammatory Murine Skin Responses to UV-B Light Are Partially Dependent on Endothelin-1 and Mast Cells Am. J. Pathol., September 1, 2006; 169(3): 815 - 822. [Abstract] [Full Text] [PDF]

				B. Donaubauer, T. Busch, R. Lachmann, M. Deja, B. Petersen, R. Francis, A. Trager, M. Ebsen, W. Boemke, and U. Kaisers Low-Dose Inhalation of an Endothelin-A Receptor Antagonist in Experimental Acute Lung Injury: ET-1 Plasma Concentration and Pulmonary Inflammation. Experimental Biology and Medicine, June 1, 2006; 231(6): 960 - 966. [Abstract] [Full Text] [PDF]

				T. Busch, B. Petersen, M. Deja, B. Donaubauer, S. Laudi, S. Jaumann, S. Bercker, W. Boemke, and U. Kaisers Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injury. Experimental Biology and Medicine, June 1, 2006; 231(6): 974 - 978. [Abstract] [Full Text] [PDF]

				H. Sylvin, E. Weitzberg, and K. Alving Endothelin-induced vascular and bronchial effects in pig airways: role in acute allergic responses J Appl Physiol, November 1, 2002; 93(5): 1608 - 1615. [Abstract] [Full Text] [PDF]

				P. J. Henry, T. S. Mann, A. C. D'Aprile, G. J. Self, and R. G. Goldie An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1072 - L1078. [Abstract] [Full Text] [PDF]

				M. T. Borchers, P. J. Justice, T. Ansay, V. Mancino, M. P. McGarry, J. Crosby, M. I. Simon, N. A. Lee, and J. J. Lee Gq Signaling Is Required for Allergen-Induced Pulmonary Eosinophilia J. Immunol., April 1, 2002; 168(7): 3543 - 3549. [Abstract] [Full Text] [PDF]

				M. J. Shaw, H. Shennib, N. Bousette, E. H. Ohlstein, and A. Giaid Effect of endothelin receptor antagonist on lung allograft apoptosis and NOSII expression Ann. Thorac. Surg., August 1, 2001; 72(2): 386 - 390. [Abstract] [Full Text] [PDF]

				F. Finsnes, T. Lyberg, G. Christensen, and O. H. Skjonsberg Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L659 - L665. [Abstract] [Full Text] [PDF]

				M Roland, A Bhowmik, R J Sapsford, T A R Seemungal, D J Jeffries, T D Warner, and J A Wedzicha Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease Thorax, January 1, 2001; 56(1): 30 - 35. [Abstract] [Full Text]

				M. Salmon, Y.-C. Liu, J. C. W. Mak, J. Rousell, T.-J. Huang, T. Hisada, P. L. Nicklin, and K. Fan Chung Contribution of Upregulated Airway Endothelin-1 Expression to Airway Smooth Muscle and Epithelial Cell DNA Synthesis after Repeated Allergen Exposure of Sensitized Brown-Norway Rats Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 618 - 625. [Abstract] [Full Text]

				F. FINSNES, G. CHRISTENSEN, T. LYBERG, O. M. SEJERSTED, and O. H. SKJONSBERG Increased Synthesis and Release of Endothelin-1 during the Initial Phase of Airway Inflammation Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1600 - 1606. [Abstract] [Full Text] [PDF]

				T. Tonnessen, P. Kristian Lunde, A. Giaid, O. M Sejersted, and G. Christensen Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide Cardiovasc Res, September 1, 1998; 39(3): 633 - 643. [Abstract] [Full Text] [PDF]

				H. SHENNIB, A. G. L. LEE, J. Q. KUANG, M. YANAGISAWA, E. H. OHLSTEIN, and A. GIAID Efficacy of Administering an Endothelin-receptor Antagonist (SB209670) in Ameliorating Ischemia-Reperfusion Injury in Lung Allografts Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1975 - 1981. [Abstract] [Full Text] [PDF]